Transplantation and cellular therapy
Efficacy and Safety of Belumosudil in the Treatment of Refractory Chronic Graft-Versus-Host Disease.
Fernando Gibran-Nunes, Isabella Michelon, Faizan Bashir, Maria Perez, Bianca de Aquino, Yana Novis, Luciana Tucunduva
Published: 202510.1016/j.jtct.2025.10.016
No abstract available for this study.